Arvast-F 5/67 MG Tablet
Manufactured by: Intas Pharmaceuticals Ltd.
Composition: Rosuvastatin (5 mg) + Fenofibrate (67 mg)
Pack size: 10 Tablet per strip
Drug type: Dyslipidaemic Agents
Prescription Required: Yes
Primary Uses: High cholesterol, High triglycerides, Hyperlipidemia
What is Arvast-F 5/67 mg Tablet?
Arvast-F 5/67 mg Tablet is a combination of two dyslipidaemic agents: Fenofibrate and Rosuvastatin that is used to reduce the levels of high cholesterol and triglycerides in the blood.
Arvast-F 5/67 mg Tablet is used in the treatment of high cholesterol and high triglycerides level in the blood.
How Does the Drug Work?
Arvast-F 5/67 mg Tablet is a lipid-lowering drug. It works by inhibiting an enzyme -HMG-CoA-reductase that is required to produce cholesterol in the body. Hence decreases the level of high cholesterol (LDL) and triglycerides.
Common Side Effects of Arvast-F 5/67 mg Tablet:
List of major side effects of Arvast-F 5/67 mg Tablet
- Joint pain
- Acid or sour stomach
- Blood in urine
- Redness of the skin
- Muscle pain
How to Use Arvast-F 5/67 mg Tablet?
Arvast-F 5/67 mg Tablet is taken by mouth by swallowing it completely with adequate water. Do not chew and break the medication. It may be taken with or without food as prescribed by the doctor.
Precautions to be taken:
Useful precautions to be taken while using Arvast-F 5/67 mg Tablet
- Do not take Arvast-F 5/67 mg Tablet if you are allergic to any ingredient in the drug formulation.
- Pregnant and lactating women should take this medication on doctor’s advice.
- Inform to your doctor immediately if you experience persistent headache and Joint pain while taking this medication.
- Alcohol consumption is not advisable during the treatment with this medicine.
- Arvast-F 5/67 mg Tablet should be used with caution in patients with liver disease or persistent high serum transaminases level.
Contraindications while using Arvast-F 5/67 mg Tablet
- This medication is contraindicated in the patients with severe renal impairment or kidney diseases.
- Arvast-F 5/67 mg Tablet is contraindicated in the patients with hypersensitivity to this medication.
Possible drug interactions of Arvast-F 5/67 mg Tablet with other compounds
- The use of Arvast-F 5/67 mg Tablet is advised against in those concurrently using immunosuppressant medication such as cyclosporin and other lipid lowering drugs (e.g. gemfibrozil).
- Concomitant treatment with itraconazole and HIV protease inhibitors can increase the serum levels of this medication.
- Arvast-F 5/67 mg Tablet may cause the increase risk of myopathy or muscle disease with niacin.
Store this medication at room temperature (between 25-30°C). Protect from sunlight and children.
In case of missed dose, skip the same and continue with your regular dosing schedule. Avoid taking double dose to make up for a missed one.
Immediately contact to your doctor as emergency medical treatment is required in case of an overdose.
- How does the Arvast-F 5/67 mg Tablet work?
Arvast-F 5/67 mg Tablet works by inhibiting an enzyme -HMG-CoA-reductase that is required to produce cholesterol in the body. Hence decreases the level of high cholesterol (LDL) and triglycerides.
- How often can I take Arvast-F 5/67 mg Tablet?
Arvast-F 5/67 mg Tablet should be used at fixed dose and duration as prescribed by your doctor.
- Is Arvast-F 5/67 mg Tablet safe to use during pregnancy?
The pregnant women should use Arvast-F 5/67 mg Tablet as prescribed by the doctor.
- Can I take Arvast-F 5/67 mg Tablet in diabetic condition?
Diabetic patients should take Arvast-F 5/67 mg Tablet on doctor’s consultation.